Hyperglycemia newly detected by glycated hemoglobin affects all-cause mortality in coronary artery disease patients: a retrospective cohort study

作者：Wei, Wen; Liang, Yan; Guo, Dachuan; Xu, Xinghao; Xu, Qingbo; Li, Shanggang; Li, Yuqi; Liu, Jin; Liu, Yong; Tu, Mei; Chen, Kaihong^*; Chen, Hong^*; Chen, Shiqun^*

来源：Diabetes Research and Clinical Practice, 2022, 191: 110053.

DOI：10.1016/j.diabres.2022.110053

• Hyperglycemia
• Coronary artery disease
• Prognosis
• HbA1c

Aims: We aim to assess the relationship between hyperglycemia and long-term prognosis in CAD patients without known diabetes.Methods: In this retrospective observational study, we enrolled 11,384 CAD patients without known diabetes. Newly detected diabetes was defined as HbA1c >= 6.5 %, and prediabetes was defined as HbA1c ranging from 5.7 to 6.4 %.The association between hyperglycemia and long-term all-cause mortality was examined using Cox proportional hazards regression analysis.Results: According to HbA1c level, 8207 (72.1 %) patients had hyperglycemia, including 13.0 % with diabetes and 59.1 % with prediabetes. During a median follow-up of 4.9 years, 1157(10.2 %) patients died. Compared with normoglycemia, hyperglycemia was associated with increased risk for long-term mortality (adjusted hazard ratio for diabetes and prediabetes: 1.23 [95 % confidence interval (CI): 1.00 to 1.51] and 1.17 [95 % CI: 1.01 to 1.36], respectively).Conclusions: Hyperglycemia detected by HbA1c was common in CAD patients without known diabetes and was associated with increased long-term mortality. It is necessary to routinely use HbA1c to assess glucose metabolic status in CAD patients and treat hyperglycemia as early as possible to reduce the risk of adverse outcomes.

• 单位
  广东省心血管病研究所; 1; 中山大学; 广东省人民医院; 南方医科大学